UroGen Pharma (URGN) Interest Coverage Ratio (2017 - 2026)
UroGen Pharma (URGN) posted quarterly Interest Coverage Ratio of 3.68 for Q1 2026, up 97.8% year-on-year from 1.86 in Q1 2025, and up 95.3% on a QoQ basis from 78.34 in Q4 2025.
UroGen Pharma (URGN) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
UroGen Pharma (URGN) has reported Interest Coverage Ratio for 10 consecutive years, with 3.68 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio rose 97.8% year-over-year to 3.68 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19.67 (up 81.65% YoY) and the FY2025 annual result came in at 0.63, down 9.58% from the prior year.
- Interest Coverage Ratio improved to 3.68 in Q1 2026 per URGN's latest filing, from 78.34 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for URGN reached as high as 3.68 in Q1 2026 and fell as low as 167.79 in Q1 2025.
- A 5-year average of 43.83 and a median of 15.99 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 99.91% — and 2024, when it tumbled 1027.99%.
- Year by year, Interest Coverage Ratio stood at 68.99 in 2022, then advanced by 27.23% to 50.2 in 2023, then plunged by 151.56% to 126.29 in 2024, then jumped by 37.97% to 78.34 in 2025, then soared by 95.3% to 3.68 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 3.68, 78.34, and 4.56 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | UroGen Pharma | 2.13 Bn | 1.99 Bn | 46.82 Mn | -3.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.68 |
| Dec 31, 2025 | -78.34 |
| Sep 30, 2025 | -4.56 |
| Jun 30, 2025 | -8.64 |
| Mar 31, 2025 | -167.79 |
| Dec 31, 2024 | -126.29 |
| Sep 30, 2024 | -15.99 |
| Jun 30, 2024 | -19.74 |
| Mar 31, 2024 | -92.92 |
| Dec 31, 2023 | -50.20 |
| Sep 30, 2023 | -6.48 |
| Jun 30, 2023 | -6.50 |
| Mar 31, 2023 | -8.24 |
| Dec 31, 2022 | -68.99 |
| Sep 30, 2022 | -5.60 |
| Jun 30, 2022 | -6.98 |
| Mar 31, 2022 | -74.18 |
| Dec 31, 2021 | 13.89 |
| Jun 30, 2021 | -7,607.67 |
| Mar 31, 2021 | -12.11 |